Skip to main content

Table 4 Comparison of the sputum-culture convention rate in placebo and QBDT group in subgroup by drug sensitivity

From: Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen

 Placebo (n = 88)QBDT (n = 93)OR (95% CI)P value
Drug sensitivityNegative
n (%)
Positive
n (%)
Withdrawal
n (%)
Negative
n (%)
Positive
n (%)
Withdrawal
n (%)
PyrazinamideSensitive56 (76.7)11 (15.1)6 (8.2)63 (88.7)3 (4.2)5 (7.0)0.42 (0.17–1.04)0.06
Resistant5(33.3)9 (60.0)1 (6.7)11(50.0)5 (22.7)6 (27.3)0.50 (0.13–1.95)0.32
EthambutolSensitive52 (73.2)16 (22.5)3 (4.2)64 (82.1)5 (6.4)9 (11.5)0.60 (0.27–1.31)0.20
Resistant9 (52.9)4 (23.5)4 (23.5)10 (66.7)3 (20.0)2 (13.3)0.56 (0.13–2.36)0.43
StreptomycinSensitive59 (77.6)12 (15.8)5 (6.6)70 (85.4)4 (4.9)8 (9.8)0.60 (0.26–1.35)0.21
Resistant2 (16.7)8 (66.7)2 (16.7)4 (36.4)4 (36.4)3 (27.3)0.35 (0.05–2.47)0.28
Total 61 (69.3)20 (22.7)7 (8.0)74 (79.6)8 (8.6)11 (11.8)0.58 (0.30–1.14)0.11
  1. QBDT Qinbudan tablet